Katrin Rittinger PhD

Katrin Rittinger obtained a degree in chemistry from the University of Heidelberg, Germany. She then went on to do a Ph.D. at the Max Planck Institute for Medical Research in Heidelberg in the group of Roger Goody, characterizing the nucleotide and oligonucleotide-binding properties of HIV reverse transcriptase and the mechanism of action of non-nucleoside RT inhibitors.

After a short postdoctoral period at the Max Planck Institute for Molecular Physiology in Dortmund, Germany, she came to the Medical Research Council National Institute for Medical Research (now part of the Francis Crick Institute) in 1996 for a second postdoc, working on the structural characterisation of 14-3-3/ligand complexes and the regulation of Rho family GTPases.

In 2000 she established her own research group and has since studied a number of multi-protein assemblies that regulate different aspects of signal transduction using biochemical and structural methods.